Cargando…
Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models
Alzheimer’s disease (AD) is a major neurodegenerative disease, but so far, it can only be treated symptomatically rather than changing the process of the disease. Recently, triazoles and their derivatives have been shown to have potential for the treatment of AD. In this study, the neuroprotective e...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370156/ https://www.ncbi.nlm.nih.gov/pubmed/35956985 http://dx.doi.org/10.3390/molecules27155035 |
_version_ | 1784766703482175488 |
---|---|
author | An, Fengmao Xuan, Xinran Liu, Zheng Bian, Ming Shen, Qingkun Quan, Zheshan Zhang, Guowei Wei, Chengxi |
author_facet | An, Fengmao Xuan, Xinran Liu, Zheng Bian, Ming Shen, Qingkun Quan, Zheshan Zhang, Guowei Wei, Chengxi |
author_sort | An, Fengmao |
collection | PubMed |
description | Alzheimer’s disease (AD) is a major neurodegenerative disease, but so far, it can only be treated symptomatically rather than changing the process of the disease. Recently, triazoles and their derivatives have been shown to have potential for the treatment of AD. In this study, the neuroprotective effects of 4-(4-(heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one (W112) against β-amyloid (Aβ)-induced AD pathology and its possible mechanism were explored both in vitro and in vivo. The results showed that W112 exhibits a neuroprotective role against Aβ-induced cytotoxicity in PC12 cells and improves the learning and memory abilities of Aβ-induced AD-like rats. In addition, the assays of the protein expression revealed that W112 reversed tau hyperphosphorylation and reduced the production of proinflammatory cytokines, tumor necrosis factor-α and interleukin-6, both in vitro and in vivo studies. Further study indicated that the regulation of mitogen-activated protein kinase/nuclear factor-κB pathways played a key role in mediating the neuroprotective effects of W112 against AD-like pathology. W112 may become a potential drug for AD intervention. |
format | Online Article Text |
id | pubmed-9370156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93701562022-08-12 Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models An, Fengmao Xuan, Xinran Liu, Zheng Bian, Ming Shen, Qingkun Quan, Zheshan Zhang, Guowei Wei, Chengxi Molecules Article Alzheimer’s disease (AD) is a major neurodegenerative disease, but so far, it can only be treated symptomatically rather than changing the process of the disease. Recently, triazoles and their derivatives have been shown to have potential for the treatment of AD. In this study, the neuroprotective effects of 4-(4-(heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one (W112) against β-amyloid (Aβ)-induced AD pathology and its possible mechanism were explored both in vitro and in vivo. The results showed that W112 exhibits a neuroprotective role against Aβ-induced cytotoxicity in PC12 cells and improves the learning and memory abilities of Aβ-induced AD-like rats. In addition, the assays of the protein expression revealed that W112 reversed tau hyperphosphorylation and reduced the production of proinflammatory cytokines, tumor necrosis factor-α and interleukin-6, both in vitro and in vivo studies. Further study indicated that the regulation of mitogen-activated protein kinase/nuclear factor-κB pathways played a key role in mediating the neuroprotective effects of W112 against AD-like pathology. W112 may become a potential drug for AD intervention. MDPI 2022-08-08 /pmc/articles/PMC9370156/ /pubmed/35956985 http://dx.doi.org/10.3390/molecules27155035 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article An, Fengmao Xuan, Xinran Liu, Zheng Bian, Ming Shen, Qingkun Quan, Zheshan Zhang, Guowei Wei, Chengxi Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models |
title | Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models |
title_full | Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models |
title_fullStr | Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models |
title_full_unstemmed | Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models |
title_short | Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models |
title_sort | anti-inflammatory activity of 4-(4-(heptyloxy)phenyl)-2,4-dihydro-3h-1,2,4-triazol-3-one via repression of mapk/nf-κb signaling pathways in β-amyloid-induced alzheimer’s disease models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370156/ https://www.ncbi.nlm.nih.gov/pubmed/35956985 http://dx.doi.org/10.3390/molecules27155035 |
work_keys_str_mv | AT anfengmao antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels AT xuanxinran antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels AT liuzheng antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels AT bianming antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels AT shenqingkun antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels AT quanzheshan antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels AT zhangguowei antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels AT weichengxi antiinflammatoryactivityof44heptyloxyphenyl24dihydro3h124triazol3oneviarepressionofmapknfkbsignalingpathwaysinbamyloidinducedalzheimersdiseasemodels |